Related references
Note: Only part of the references are listed.Sorafenib suppresses TGF-β responses by inducing caveolae/lipid raft-mediated internalization/degradation of cell-surface type II TGF-β receptors: Implications in development of effective adjunctive therapy for hepatocellular carcinoma
Chih-Ling Chung et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Enhanced tenogenic differentiation and tendon-like tissue formation by tenomodulin overexpression in murine mesenchymal stem cells
Yongkang Jiang et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2017)
A comprehensive map of molecular drug targets
Rita Santos et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Adiponectin Is Involved in Connective Tissue Growth Factor-Induced Proliferation, Migration and Overproduction of the Extracellular Matrix in Keloid Fibroblasts
Limin Luo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach
Marco Presta et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
Jingang Huang et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Novel Mechanisms for the Antifibrotic Action of Nintedanib
Sunad Rangarajan et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)
Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways
Wenbo Wang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment
Jonathan P. Andrews et al.
MATRIX BIOLOGY (2016)
Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2016)
Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis
Siri T. Lehtonen et al.
RESPIRATORY RESEARCH (2016)
FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis
Claudia A. Staab-Weijnitz et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Aspidin PB, a novel natural anti-fibrotic compound, inhibited fibrogenesis in TGF-β1-stimulated keloid fibroblasts via PI-3K/Akt and Smad signaling pathways
Rengang Song et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
Lutz Wollin et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Nintedanib: From Discovery to the Clinic
Gerald J. Roth et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Profile of nintedanib in the treatment of solid tumors: the evidence to date
Niranjan Awasthi et al.
ONCOTARGETS AND THERAPY (2015)
Potent Dual Inhibitors of TORC1 and TORC2 Complexes (KU-0063794 and KU-0068650) Demonstrate In Vitro and Ex Vivo Anti-Keloid Scar Activity
Farhatullah Syed et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation
Y-L Chen et al.
CELL DEATH & DISEASE (2013)
Critical Role of Transforming Growth Factor Beta in Different Phases of Wound Healing
Mohammadreza Pakyari et al.
ADVANCES IN WOUND CARE (2013)
Keloid Disease Can Be Inhibited by Antagonizing Excessive mTOR Signaling With a Novel Dual TORC1/2 Inhibitor
Farhatullah Syed et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
In vivo tendon engineering with skeletal muscle derived cells in a mouse model
Bo Chen et al.
BIOMATERIALS (2012)
Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β/Smad pathway
S. He et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Molecular Pathways: Fibroblast Growth Factor Signaling: A New Therapeutic Opportunity in Cancer
A. Nigel Brooks et al.
CLINICAL CANCER RESEARCH (2012)
PAI-1 in tissue fibrosis
Asish K. Ghosh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Altered angiogenic balance in keloids: a key to therapeutic intervention
Nirupa Shyam Mogili et al.
TRANSLATIONAL RESEARCH (2012)
Mechanisms of transforming growth factor β1/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts
S. He et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Human skin keloid fibroblasts display bioenergetics of cancer cells
Annette S. Vincent et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
TGF-β-induced fibrosis and SMAD signaling:: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring
Kenneth R. Cutroneo
WOUND REPAIR AND REGENERATION (2007)
Effect of heat shock protein 47 on collagen accumulation in keloid fibroblast cells
J.-J. Chen et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis
N. I. Chaudhary et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts
Zimin Wang et al.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2007)
Modulation of collagen synthesis in keloid fibroblasts by silencing Smad2 with siRNA
Zhongyu Gao et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2006)
Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management
Alison E. Slemp et al.
CURRENT OPINION IN PEDIATRICS (2006)
Stat3 contributes to keloid pathogenesis via promoting collagen production, cell proliferation and migration
C. P. Lim et al.
ONCOGENE (2006)
Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vascular function
S Mukherjee et al.
CIRCULATION RESEARCH (2006)
P38 MAP kinase mediates transforming growth factor-β2 transcription in human keloid fibroblasts
W Xia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
Growth factor receptors, lipid rafts and caveolae: An evolving story
LJ Pike
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2005)
Upregulation of transforming growth factor-β1 and vascular endothelial growth factor in cultured keloid fibroblasts:: relevance to angiogenic activity
M Fujiwara et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2005)
Pathogenesis of fibrosis:: role of TGF-β and CTGF
H Ihn
CURRENT OPINION IN RHEUMATOLOGY (2002)
Share Paper
